drugset / Trial / NCT00050622

Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)

NCT00050622

RandomizedCrossoverTriple-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of behavioral treatment, drug treatment, and combined treatment for children with Attention Deficit Hyperactivity Disorder (ADHD). This study will also examine the interactions between different levels of behavioral and drug treatments.

Timeline

Start
2001-09
Primary completion
2004-08
Completion
2005-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule 0.15 mg/kg
Comparator Methylphenidate Small molecule 0.3 mg/kg
Comparator Methylphenidate Small molecule 0.6 mg/kg